---
title: "editorial sore throat"
year: 2024
month: 04
journal: "American Family Physician"
volume: "109-110"
issue: "04"
pages: ""
doi: ""
pmid: ""
source: "PDF Extraction"
pdf_available: true
original_pdf: "2024-04-editorial-sore-throat.pdf"
extracted_date: "2025-08-10"
keywords: []
evidence_level: ""
clinical_significance: ""
---

# editorial sore throat

                                                                Editorials
  Management of Sore Throat:​Time to Update
                                   Mark H. Ebell, MD, MS, University of Georgia, Athens, Georgia
                               Henry C. Barry, MD, MS, Michigan State University, East Lansing, Michigan


See related article on page 343.                                                 This analysis used 2002 costs and had lower sensitivity than
                                                                                 has been documented with more modern rapid antigen tests
Sore throat is among the most common infections that we                          (80% then vs. 86% to 97% now), so it is almost certainly even
manage in primary care. Doing it right is important, which                       less cost-effective today.14
means avoiding overtesting, overtreatment, and overmedi-                            Because rheumatic heart disease is so rare in the United
calization of the patient with a sore throat. Medicalization                     States, the primary benefit of using antibiotics is symptom
in this context refers to how our decisions regarding testing                    reduction, with a number needed to treat of 6 for improve-
and treatment can “train” our patients to believe that they                      ment by day 3, and possibly the reduction of spread to oth-
always need these interventions, and inappropriate medi-                         ers (although most close contacts have likely already been
calization is an important driver of unnecessary testing and                     exposed by the time the patient is evaluated).15,16 In 2023, an
antibiotic overuse.1                                                             international group of experts in primary care respiratory
   Group A beta-hemolytic streptococcus (GABHS) is                               infections published the first international guideline for the
detected in approximately 10% of adults and 20% to 30% of                        management of sore throat (https://www.tandf​online.​com/
children with sore throat.2 When detected, GABHS is usu-                         doi/epdf/10.1080/23744235. ​ 2 023. ​ 2191714?​ n eed ​ Access=​
ally pathogenic in adults, but children are often carriers;                      true).3 The guideline focuses on avoiding testing and anti-
therefore, GABHS is the cause of symptoms in only two-                           biotic use for patients with uncomplicated sore throat (i.e.,
thirds of positive test results in children. 3 Although acute                    mild to moderate sore throat accompanied by cough with
rheumatic fever and rheumatic heart disease were once rela-                      no red flags), reserving evaluation, testing, and possibly
tively common complications and remain a problem in other                        antibiotic use for those at risk of complicated or severe
parts of the world,4 the incidence is less than 1 per 100,000                    disease. 3 Using rapid antigen testing for streptococcus,
children per year in the United States.5 This is also found in                   followed by prescribing antibiotics, is not recommended
countries with much lower rates of testing and antibiotic use                    for any children with uncomplicated sore throat in the
for streptococcal pharyngitis.6                                                  Netherlands and Belgium, whereas other European coun-
   One important change is that present-day rapid antigen                        tries recommend using a validated clinical decision rule
tests for streptococcus are more sensitive than older tests,                     to guide therapy, with no testing or antibiotics in patients
with current tests having an overall sensitivity of 86% and                      at low risk.3
specificity of 96% in one meta-analysis.7 Nucleic acid ampli-                       The small benefit of antibiotics must be balanced against
fication tests are also increasingly available at the point                      harms, including rash, diarrhea, upset stomach, and, rarely,
of care and are even more sensitive than older rapid tests.                      Clostridioides difficile infection and anaphylaxis. For those
Although these nucleic acid amplification tests are expen-                       with an uncomplicated infection and no red flags for serious
sive, their sensitivity of 93% to 99% and specificity of 99% are                 or complicated disease, shared decision-making with patients
similar to or exceed those of a throat culture.8,9                               or their caregivers is appropriate. Some patients may value
   With this changing landscape, it is time to rethink recom-                    avoiding unnecessary antibiotics more than others, which
mendations from the Infectious Diseases Society of Amer-                         is reasonable. The guideline by Gunnarsson and colleagues
ica and the American Academy of Pediatrics, which call for                       includes easy-to-use flowcharts for the initial decision on
a backup throat culture in children with a negative result                       whether an office visit is needed and classification of sore
on rapid antigen testing.10,11 A large study found that only                     throat severity during an in-person visit.3
2.4% of throat cultures following a negative result on rapid                        There is good evidence that routinely testing every patient
antigen testing in children detected GABHS pharyngitis.12                        with a sore throat for GABHS, regardless of their risk, and
Another study found that only 1% of children with a nega-                        prescribing antibiotics to anyone with a positive test result
tive modern rapid antigen test had a positive backup throat                      medicalizes sore throat and builds a mentality in our
culture.13 A cost-effectiveness analysis estimated that backup                   patients that they need to be tested and prescribed antibi-
cultures after a negative test would detect only 11 additional                   otics every time they have a sore throat.1 There is also good
cases of rheumatic heart disease in the entire United States                     evidence that prescribing antibiotics shortens visit length
annually, at a cost of $8 million per additional case detected.                  by 1 minute and that patient satisfaction is driven not by

Downloaded
April 2024 ◆ from the American
             Volume            Family4 Physician website at www.aafp.org/afp.
                      109, Number                                                    © 2024 American Academy of American
                                                                              Copyright
                                                               www.aafp.org/afp                                              Family
                                                                                                                 Family Physicians.     the private, 301
                                                                                                                                    ForPhysician     non-
commercial use of one individual user of the website. All other rights reserved. Contact copyrights@aafp.org for copyright questions and/or permission requests.
                                                                       EDITORIALS


receipt of antibiotics but by the perception that their clini-                     7. Lean WL, Arnup S, Danchin M, et al. Rapid diagnostic tests for group A strep-
                                                                                      tococcal pharyngitis:​a meta-analysis. Pediatrics. 2014;​134(4):​7 71-781.
cian listened, cared about them, and offered reassurance and
                                                                                  8. Gerber MA. Comparison of throat cultures and rapid strep tests for
advice.17,18 Therefore, our discussions with patients should                         diagnosis of streptococcal pharyngitis. Pediatr Infect Dis J. 1989;​8(11):​
focus on that most sore throats are viral and uncomplicated,                         820-824.
that antibiotics can also be harmful, that complications are                       9. Mustafa Z, Ghaffari M. Diagnostic methods, clinical guidelines, and
exceedingly rare in the United States, and that we have tools                         antibiotic treatment for group A streptococcal pharyngitis:​a narrative
                                                                                      review. Front Cell Infect Microbiol. 2020;​10:​563627.
to provide symptomatic relief while patients heal.                                10. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for
                                                                                      the diagnosis and management of group A streptococcal pharyngitis:​
 Editor’s Note:​ Dr. Ebell is deputy editor for evidence-                             2012 update by the Infectious Diseases Society of America [published
 based medicine for AFP.                                                              correction appears in Clin Infect Dis. 2014;​58(10):​1496]. Clin Infect Dis.
                                                                                      2012;​55(10):​1 279-1282.
                                                                                  11. American Academy of Pediatrics Committee on Infectious Diseases.
Address correspondence to Mark H. Ebell, MD, MS, at ebell@​uga.                       Group A streptococcal infections. In:​Red Book:​ 2021-2024 Report of
edu. Reprints are not available from the authors.                                     the Committee on Infectious Diseases. 32nd ed. American Academy of
                                                                                      Pediatrics;​ 2021:​694-701.
Author disclosure:​Dr. Ebell was a member of the guideline
group cited in reference 3. The authors have no relevant finan-                   12. Mayes T, Pichichero ME. Are follow-up throat cultures necessary when
                                                                                      rapid antigen detection tests are negative for group A streptococci? Clin
cial relationships.
                                                                                      Pediatr (Phila). 2001;​40(4):​191-195.

References                                                                        13. Rystedt K, Hedin K, Tyrstrup M, et al. Agreement between rapid anti-
                                                                                      gen detection test and culture for group A streptococcus in patients
 1. Little P, Rumsby K, Kelly J, et al. Information leaflet and antibiotic pre-       recently treated for pharyngotonsillitis - a prospective observational
    scribing strategies for acute lower respiratory tract infection:​a random-        study in primary care. Scand J Prim Health Care. 2023;​41(1):​91-97.
    ized controlled trial. JAMA. 2005;​293(24):​3029-3035.                        14. Ehrlich JE, Demopoulos BP, Daniel KR Jr., et al. Cost-effectiveness
2. Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyn-                of treatment options for prevention of rheumatic heart disease from
   gitis and streptococcal carriage in children:​a meta-analysis. Pediatrics.         group A streptococcal pharyngitis in a pediatric population. Prev Med.
   2010;​1 26(3):​e557-e564.                                                          2002;​35(3):​250-257.
3. Gunnarsson RK, Ebell M, Centor R, et al. Best management of patients           15. Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore
   with an acute sore throat - a critical analysis of current evidence and            throat in children and adults. Cochrane Database Syst Rev. 2021;​1 2(12):​
   a consensus of experts from different countries and traditions. Infect             CD000023.
   Dis (Lond). 2023;​55(6):​384-395.                                              16. McGuire E, Li A, Collin SM, et al. Time to negative throat culture fol-
4. Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and                 lowing initiation of antibiotics for pharyngeal group A Streptococcus:​
   national burden of rheumatic heart disease, 1990-2015. N Engl J Med.               a systematic review and meta-analysis up to October 2021 to inform
   2017;​377(8):​713-722.                                                             public health control measures. Euro Surveill. 2023;​28(15):​2200573.
5. Bradley-Hewitt T, Longenecker CT, Nkomo V, et al. Trends and presen-           17. Linder JA, Singer DE, Stafford RS. Association between antibiotic pre-
   tation patterns of acute rheumatic fever hospitalisations in the United            scribing and visit duration in adults with upper respiratory tract infec-
   States. Cardiol Young. 2019;​29(11):​1 387-1390.                                   tions. Clin Ther. 2003;​25(9):​2419-2430.
6. Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart dis-       18. Hamm RM, Hicks RJ, Bemben DA. Antibiotics and respiratory infec-
   ease in a Swedish nationwide hospital-based register study. Heart. 2017;​          tions:​are patients more satisfied when expectations are met? J Fam
   103(21):​1696-1703.                                                                Pract. 1996;​43(1):​56-62. ■




302 American Family Physician                                     www.aafp.org/afp                                     Volume 109, Number 4 ◆ April 2024
